Clinical Trials Directory

Trials / Completed

CompletedNCT01504061

Mederma to Reduce Appearance of Post Surgical Scars

The Comparison of Mederma® N&I to Mederma® Ultra Gel to Reduce the Appearance of Post Surgical Scars

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Merz North America, Inc. · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This is a single-center, 20-subject, investigator-blinded study to evaluate the effect of Mederma N\&I to Mederma Ultra Gel on the appearance of post-surgical scars.

Detailed description

This is a 10-week research study designed to compare the effect of two gels on the appearance of post surgical scarring of the chest and/or back. The subject will be asked to identify two symmetrical skin growths that they would like to have removed: one on the left chest and/or back and one on the right chest and/or back. Additionally, the subject will identify a third skin growth that they would like removed which is a reasonable distance from the two symmetrical skin growths and will be located either on the back or the chest. Inclusion Criteria: * Healthy male and non pregnant female subjects ≥18 years of age * have seborrheic keratoses on the right and left chest and/or back Exclusion Criteria: -Subjects with known allergies or sensitivities to ingredients contained in the test product including onion extract and Lidocaine.

Conditions

Interventions

TypeNameDescription
OTHERMederma N&ITopical gel applied three times a day for eight weeks.
OTHERMederma Ultra GelTopical gel applied once daily for eight weeks.

Timeline

Start date
2012-01-01
Primary completion
2012-06-01
Completion
2012-08-01
First posted
2012-01-05
Last updated
2013-10-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01504061. Inclusion in this directory is not an endorsement.